GIBSON DANIEL GLENN (Chief Technology Officer) reported 1 transaction at TELESIS BIO INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/29/2024ACC: 0000950170-24-023458
Officer· Chief Technology Officer
Since Jun 2021
-2.27K
Net shares
Net seller
$1.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.27K
Price / share
$0.53
Trade value
$1.21K
% of position
2.2%
2/27/2024
102.08K→99.82K
Total
Net shares
−2.27K
Net value
-$1.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2024 | F · Tax Withholding | −2.27K | $0.53 | $1.21K | 2.2% | 102.08K | 99.82K |
| Total | −2.27K | -$1.21K | ||||||
Derivative Transactions0
No derivative transactions reported